PTG-0861
PTG-0861 is a selective histone deacetylase 6 (HDAC6) inhibitor with the IC50 value of 5.92 nM. PTG-0861 induces apoptosis and can be used in the study of acute myeloid leukemia, multiple myeloma and other hematological cancers.
For research use only. We do not sell to patients.
- CAS No.: 2494082-34-5
- Formula: C15H9F5N2O3
- Molecular Weight:360.24
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
HDAC6 5.92 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Fibroblast | IC50 |
11.5 μM
Compound: 54; PTG-0861
|
Cytotoxicity against human fibroblasts measured after 72 hrs by spectrophotometer method
Cytotoxicity against human fibroblasts measured after 72 hrs by spectrophotometer method
|
[PMID: 32615502] |
| Fibroblast | IC50 |
14.6 μM
Compound: 54; PTG-0861
|
Cytotoxicity against pooled human fibroblasts measured after 72 hrs by spectrophotometer method
Cytotoxicity against pooled human fibroblasts measured after 72 hrs by spectrophotometer method
|
[PMID: 32615502] |
| HUVEC | IC50 |
10.3 μM
Compound: 54; PTG-0861
|
Cytotoxicity against human HUVEC cells measured after 72 hrs by spectrophotometer method
Cytotoxicity against human HUVEC cells measured after 72 hrs by spectrophotometer method
|
[PMID: 32615502] |
| MM1.S | IC50 |
1.9 μM
Compound: 54; PTG-0861
|
Cytotoxicity against human MM1.S cells measured after 72 hrs by spectrophotometer method
Cytotoxicity against human MM1.S cells measured after 72 hrs by spectrophotometer method
|
[PMID: 32615502] |
| MV4-11 | IC50 |
1.85 μM
Compound: 1
|
Cytotoxicity against human MV4-11 cells assessed as cell viability incubated for 72 hrs by Cell titer-blue assay
Cytotoxicity against human MV4-11 cells assessed as cell viability incubated for 72 hrs by Cell titer-blue assay
|
[PMID: 34101461] |
| MV4-11 | IC50 |
1.85 μM
Compound: 54; PTG-0861
|
Cytotoxicity against human MV4-11 cells measured after 72 hrs by spectrophotometer method
Cytotoxicity against human MV4-11 cells measured after 72 hrs by spectrophotometer method
|
[PMID: 32615502] |
| RPMI-8226 | IC50 |
4.94 μM
Compound: 54; PTG-0861
|
Cytotoxicity against human RPMI-8226 cells measured after 72 hrs by spectrophotometer method
Cytotoxicity against human RPMI-8226 cells measured after 72 hrs by spectrophotometer method
|
[PMID: 32615502] |
In Vitro
PTG-0861 (compound 54) (0.1-5 μM, 6 hours) stimulates the expression of acetylated a-tubulin and has inhibitory activity against HDAC6 with the IC50 value of 0.59 μM[1].
PTG-0861 (compound 54) (0-4 μM, 18 hours) can induce apoptosis in a dose-dependent manner and has some cytotoxic effect[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MV4-11 cells
-
Concentration:0.1-5 μM
-
Incubation Time:6 hours
-
Result:Induced the accumulation of acetylated a-tubulin expression at 500 nM.
-
Cell Line:HeLa cells
-
Concentration:0-2 μM
-
Incubation Time:6 hours
-
Result:Increased levels of acetylated a-tubulin at 0.1 μM.
-
Cell Line:MV4-11 cells
-
Concentration:0-4 μM
-
Incubation Time:18 hours
-
Result:Induced about 18% cells late apoptosis at 4 μM while at low dose 0.25 μM only about 5%.
-
Cell Line:Hematological cancer cell lines MV4-11, MM.1S, and RPMI 8226
-
Concentration:1.24-4.94 μM
-
Incubation Time:72 hours
-
Result:Showed cytotoxic effects on MV4-11, MM.1S, and RPMI 8226 with the IC50 value of 1.85 μM,1.9 μM,4.94 μM, respectively.
-
Cell Line:
-
Concentration:
-
Incubation Time:
-
Result:Result: The pharmacokinetic parameters of PTG-0861 in vitro
Parameter PTG-0861 Percent Remaining (%) 0 min 100.00 Percent Remaining (%) 30 min 96.41 Percent Remaining (%) 60 min 97.98 Percent Remaining (%) 120 min 97.08 T1/2 (min) ∞ T1/2 (min) 50.85 ± 3.37 CLint (mL/min/106 cells) 27.32 ± 1.81 -Log Pe 5.66 ± 0.02 Papp (A-B) (10 6, cm/s) 1.33 ± 0.03 Papp (B-A) (10 6, cm/s) 0.94 ± 0.13 Efflux Ratio 0.71 ± 0.08
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD1 mice[1]
-
Dosage:20 mg/kg
-
Administration:Oral administration; everyday; 5 days
-
Result:No weight loss in mice and no obvious toxicity.
-
Animal Model:Male CD1 mice[1]
-
Dosage:20 mg/kg
-
Administration:Intraperitoneal injection; once
-
Result:The pharmacokinetic parameters of PTG-0861 in vivo
Parameter PTG-0861 half-life 0.25 h Cmax 526 ng/mL AUClast 190 h∗ng/mL AUCinf 219 h∗ng/mL AUC Extr(%) 0.324 MRT(h) 0.350 AUC/D(h∗mg/mL) 9.5
Chemical Information
-
CAS No. 2494082-34-5
-
Molecular Weight 360.24
-
Formula C15H9F5N2O3
-
SMILES
O=C(NCC1=CC=C(C(NO)=O)C=C1)C2=C(F)C(F)=C(F)C(F)=C2F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)